Web-based Mind-body Program to Improve Resilience Among Risky Substance Users With Persistent Upper Extremity Pain
Feasibility RCT of Web-based Mind-body Treatment to Enhance Resilience Among Patients With Painful Nontraumatic Upper-extremity Conditions and Commorbid Risky Substance Use
2 other identifiers
interventional
50
1 country
1
Brief Summary
The investigator aims to conduct a feasibility randomized controlled trial (RCT) (N=50) to test the feasibility, acceptability, and credibility of an asynchronous web-based mind-body intervention (Toolkit for Resilient Life beyond Pain and Substance Use; Web-TIRELESS) versus web-based minimally enhanced usual care (Web-MEUC) among adult patients with a painful non-traumatic upper-extremity condition(s) (PNUC) and commorbid risky substance use. Deliverables: \[1\] Adapt and refine open pilot protocol, patient recruitment, and other study materials. \[2\] Assess the feasibility, acceptability, and credibility of Web-TIRELESS and Web-MEUC in preparation for future research.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 19, 2025
CompletedFirst Posted
Study publicly available on registry
May 27, 2025
CompletedStudy Start
First participant enrolled
September 15, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
March 1, 2027
March 13, 2026
March 1, 2026
1.5 years
May 19, 2025
March 11, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (8)
Credibility and Expectancy Questionnaire (CEQ)
Assesses the degree to which one believes the intervention will effectively manage their condition, substance use, and related worry. Possible scores range from 3 to 27 for both the credibility and the expectancy subscales. Higher scores represent higher credibility and expectancy.
Baseline (0 Weeks)
Client Satisfaction Questionnaire to assess satisfaction with/acceptability of treatment
Participants' satisfaction with treatment received after completion. The score range is 0-12. Higher scores indicate greater satisfaction.
Post-Test (5 Weeks)
The User Experience Scale to assess participants' satisfaction with (acceptability of) web-based delivery
This measure will assess how well patients like the Wed-based program content and delivery. Total raw scores range from 22 to 110 with higher scores indicating greater satisfaction with the platform.
Post-Test (5 Weeks)
The percent of patients that agree to participate to assess feasibility of recruitment
The percent of eligible patients approached that agree to participate.
Baseline (0 Weeks)
Rate at which program was accepted, measured by attendance to assess acceptability of treatment
The proportion of Web-TIRELESS participants who complete \> or = 3 of 4 sessions.
Post-Test (5 Weeks)
Adherence to homework
Rate of Web-TIRELESS participant's completion of homework assigned throughout the study.
Throughout intervention completion, an average of 1 month
Rate of participant's completion of self-report measures to assess feasibility of assessments
Investigators will report number of patients who complete assessments at each time-point.
Baseline (0 Weeks), Post-Test (5 Weeks)
Adverse Events
Any self-reported or observed negative events related to participation.
Throughout intervention completion, an average of 1 month
Secondary Outcomes (11)
Graded Chronic Pain Scale (GCPS)
Baseline (0 Weeks), Post-Test (5 Weeks), Follow-Up (6 Months)
Disabilities of the Arm, Shoulder and Hand (DASH)
Baseline (0 Weeks), Post-Test (5 Weeks), Follow-Up (6 Months)
Patient Reported Outcomes Measurement Information System (PROMIS) Emotional Distress - Depression-Short Form 8a v1.0
Baseline (0 Weeks), Post-Test (5 Weeks), Follow-Up (6 Months)
PROMIS Emotional Distress - Anxiety-Short Form 8a v1.0
Baseline (0 Weeks), Post-Test (5 Weeks), Follow-Up (6 Months)
Pain Catastrophizing Scale (PCS)
Baseline (0 Weeks), Post-Test (5 Weeks), Follow-Up (6 Months)
- +6 more secondary outcomes
Study Arms (2)
Web-TIRELESS
EXPERIMENTALA 4-session, asynchronous, web-based mind-body pain and substance use management intervention.
Web-MEUC
ACTIVE COMPARATOROpen access to a web-based pamphlet containing brief, educational information and coping techniques.
Interventions
An educational information web-based pamphlet, containing brief, summarized information tailored for the respective patient population that follows topics including the trajectory of pain and adaptation after non-traumatic painful upper extremity conditions, the role of relaxation strategies to manage pain, and the importance of returning to engagement in activities of daily living.
This is a self-administered web-based intervention that consists of 4 on-demand sessions, each \~30 minutes long, that teach mind-body skills, cognitive-behavioral strategies (e.g., reframing, pain and substance use urge surfing), activity pacing, acceptance and commitment skills, and psychoeducation on the association between substance use and pain. The program aims to increase patients' physical and emotional functioning and decrease pain intensity and maladaptive substance use behaviors.
Eligibility Criteria
You may qualify if:
- Outpatient adults seeking care in the Hand and Arm Center
- Diagnosed with a non-traumatic painful upper-extremity condition (NPUC)
- Pain score \> 4 on the Numerical Rating Scale (NRS)
- Risky substance use (scores \>10 and \<27 for alcohol, and \>3 and \<27 for cannabis, cocaine, amphetamine-type stimulants, inhalants, sedatives, hallucinogens, opioids, tobacco products, and e-cigarette on The World Health Organization's - Alcohol, Smoking and Substance Involvement Screening Test \[WHO-ASSIST\])
- Owns a smartphone, laptop, or computer with internet access
- Age ≥18yr
- English fluency
- Ability and willingness to participate in a live video focus group and the following asynchronous Web-based intervention
You may not qualify if:
- Participation in mind-body or specialized substance abuse treatment in the past 3 months
- Practice of mindfulness \>45 minutes/week in the past 3 months
- Psychotropic medications (e.g. antidepressants) changed in the past 3 months
- Serious untreated mental illness (e.g., Schizophrenia)
- Suicidal ideation with intent or plan
- Pregnancy
- Secondary gains that may bias motivation (e.g., pending disability claim),
- Moderate to severe cognitive impairment (score ≥4 on the Short Portable Mental Status Questionnaire (SPMSQ))
- History of surgery for the presented NPUC within the past 6 months OR future plans for surgery.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jafar Bakhshaie, MD, PhD
Massachusetts General Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
May 19, 2025
First Posted
May 27, 2025
Study Start
September 15, 2025
Primary Completion (Estimated)
March 1, 2027
Study Completion (Estimated)
March 1, 2027
Last Updated
March 13, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share